- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04208126
Early Versus Late Initiation of ECMO (Extracorporal Membrane Oxygenation) Trial (ELIEO-Trial) (ELIEO)
Early Versus Late Initiation of ECMO Trial (ELIEO-Trial)
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Patients suffering acute ARDS defined according to the Berlin Definition starting from severe stage with acute onset and (i) ratio partial arterial pressure of oxygen fraction of inspired oxygen inspired oxygen fraction (PaO2/ FiO2) ≤ 200 (ii) Bilateral opacities consistent with pulmonary edema on frontal chest radiograph, and (iii) requirement for positive pressure ventilation via an endotracheal tube or non-invasive ventilation (iv) no clinical evidence of left atrial hypertension, or if measured, a Pulmonary Arterial Wedge Pressure (PAOP) less than or equal to 18 mm Hg will be treated by ECMO either within 24 hours to referral to an ARDS ECMO center or as rescue therapy after failure of conventional therapy.
Outcome measures have been chosen according to robustness and sensitivity to change. They are of high clinical impact and reflect the treatment effect desired by clinicians. Primary efficacy endpoint: All cause mortality by 28-days. Key secondary endpoints are: 1) 90 day all cause mortality 3) ICU length of stay 4) duration of mechanical ventilation support 5) frequency and duration of renal replacement therapy 6) bleeding requiring transfusions in the ICU 7) SOFA score
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Tübingen, Tyskland, 72076
- University Hospital Tubingen
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- ARDS as defined according to the Berlin Definition1
- The term "acute onset" is defined as follow: the duration of the hypoxemia criterion and the chest radiograph criterion must be ≤ 7 days at the time of randomization.
- Patients must be enrolled within 96 hours of onset of ARDS and no later than 7 days from the initiation of mechanical ventilation.
Exclusion Criteria:
- Age less than 18 years
- More than 7 days since initiation of mechanical ventilation
- more than 96 hours since meeting inclusion criteria
- patient, surrogate or physician not committed to full intensive care support
- pregnancy
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: Early ECMO
ECMO is placed immediately after admission to the intensive care unit
|
ECMO implantation immediately after ICU admission
|
Ingen indgriben: Control
Conservative therapy unless failure of therapy.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
28 day all cause mortality
Tidsramme: 28 day after study inclusion
|
28 day all cause mortality
|
28 day after study inclusion
|
90 day all cause mortality
Tidsramme: 90 day after study inclusion
|
90 day all cause mortality
|
90 day after study inclusion
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Sepsis-related organ failure assessment score (SOFA) Organ Failure Scores
Tidsramme: 1-14, 28 and 90 days after study inclusion
|
SOFA Organ Failure Scores
|
1-14, 28 and 90 days after study inclusion
|
Delirium
Tidsramme: 28 and 90 day after discharge of ICU
|
Occurence of Delirium (positive Confusion Assessment Method for the Intensive Care Unit (CAM-ICU))
|
28 and 90 day after discharge of ICU
|
discharge location
Tidsramme: 28 and 90 day after discharge of ICU
|
discharge location: a) home, b) skilled nursing facility, c) rehabilitation unit
|
28 and 90 day after discharge of ICU
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Forventet)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- ELIEO
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Acute respiratory distress syndrom
-
Tanta UniversityRekrutteringAkut lungeskade/akut respiratorisk distress syndrom (ARDS) | Respiratory Distress Syndrome, PædiatriskEgypten
-
The Second Affiliated Hospital of Chongqing Medical...Children's Hospital of Chongqing Medical University; Chongqing Medical... og andre samarbejdspartnereIkke rekrutterer endnuAcute respiratory distress syndrom | Respiratory Distress Syndrome, Akut
-
Queen's University, BelfastInnovate UK; Northern Ireland Clinical Trials UnitAktiv, ikke rekrutterendeAkut Respiratory Distress Syndrome (ARDS)Det Forenede Kongerige, Irland
-
University Hospital TuebingenAfsluttetRespiratory Distress Syndrome, VoksenTyskland
-
Policlinico HospitalAfsluttetAkut Respiratory Distress Syndrome (ARDS)Italien
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)AfsluttetRespiratory Distress Syndrome, VoksenForenede Stater
-
Michael A. MatthayThe University of Texas Health Science Center, Houston; United States Department... og andre samarbejdspartnereAfsluttetRespiratory Distress Syndrome, VoksenForenede Stater
-
Faron Pharmaceuticals LtdSeventh Framework ProgrammeAfsluttetRespiratory Distress Syndrome, VoksenSpanien, Det Forenede Kongerige, Frankrig, Italien, Finland, Tjekkiet, Belgien, Tyskland
-
Peking University Third HospitalBeijing Friendship Hospital; Beijing Shijitan Hospital, Capital Medical... og andre samarbejdspartnereAfsluttetAkut Respiratory Distress Syndrome, ARDS
-
Canadian Critical Care Trials GroupCanadian Institutes of Health Research (CIHR); McMaster University; University...AfsluttetAkut Respiratory Distress Syndrome (ARDS)Chile, Canada, Forenede Stater, Indien, Saudi Arabien
Kliniske forsøg med ECMO
-
University of MichiganAfsluttetÅndedrætssvigtForenede Stater
-
Hannover Medical SchoolAfsluttet
-
Assistance Publique - Hôpitaux de ParisMaquet CardiovascularAfsluttet
-
Hamad Medical CorporationRekrutteringKardiogent stød | Ekstrakorporal membraniltningskomplikationQatar
-
Nanjing Medical UniversityRekrutteringHjertefejl | Hjertestop | Acute respiratory distress syndrom | Kardiogent stød | Akut respirationssvigtKina
-
Jessa HospitalAfsluttet
-
Children's Hospital of Fudan UniversityChinese PLA General Hospital; Guangdong Provincial People's Hospital; The... og andre samarbejdspartnereAfsluttet
-
University of Milano BicoccaOspedale San Gerardo. S.S.U.E.M. 118 Brianza; Ospedale San Gerardo. Terapia...Ukendt
-
Kepler University HospitalAfsluttetARDS på grund af sygdom forårsaget af SARS Co-V-2Østrig
-
Dr. Alexander SupadyLudwig-Maximilians - University of Munich; University of Ulm; Klinikum Ibbenbüren og andre samarbejdspartnereSuspenderetCoronavirusinfektion | SARS-CoV-2 | Åndedrætssvigt | Ekstrakorporal membraniltning | COVID | CytokinstormTyskland